{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:40:47Z","timestamp":1792111247851,"version":"4.4.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:sec id=\"ab-yoi240082-4\"><jats:title>Importance<\/jats:title><jats:p>Whether state implementation of medical and recreational cannabis laws is associated with increased cannabis use disorder (CUD) and\/or cannabis poisoning among adults is not evident.<\/jats:p><\/jats:sec><jats:sec id=\"ab-yoi240082-5\"><jats:title>Objective<\/jats:title><jats:p>To examine state-level medical and recreational cannabis laws\u2019 associations with CUD and cannabis poisoning, overall and by sex and age subgroups.<\/jats:p><\/jats:sec><jats:sec id=\"ab-yoi240082-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>In this longitudinal cohort study, state-level CUD and cannabis poisoning diagnoses from January 2011 to December 2021 were examined across all 50 US states and the District of Columbia before and after the implementation of medical and recreational cannabis laws (MCLs and RCLs, respectively) using a staggered adoption difference-in-differences approach. Event studies were conducted to estimate the magnitude of the association for each year-quarter relative to the time of each policy implementation. This study was conducted among all adults aged 18 to 64 years enrolled in the Merative MarketScan Commercial Claims and Encounters Database, a database of employer-sponsored health insurance enrollees, with 1 year or more of continuous enrollment from 2011 to 2021. Data analysis was performed from January to August 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-yoi240082-7\"><jats:title>Exposures<\/jats:title><jats:p>State implementation of an MCL, opening a medical cannabis dispensary (MCD), allowing home cultivation of medical cannabis (HC-MC), and passage of an RCL.<\/jats:p><\/jats:sec><jats:sec id=\"ab-yoi240082-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>CUD and cannabis poisoning diagnoses per 100\u202f000 enrollees per quarter.<\/jats:p><\/jats:sec><jats:sec id=\"ab-yoi240082-9\"><jats:title>Results<\/jats:title><jats:p>This study included 110\u202f256\u202f536 enrollees, of whom 56\u202f843\u202f030 (52%) were female and the mean (SD) enrollee age was 41.0 (13.5) years. MCLs were associated with significant increases in CUD and cannabis poisoning by 31.09 (95% CI, 20.20-41.99; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) and 0.76 (95% CI, 0.52-1.00; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) diagnoses per 100\u202f000 enrollees per quarter, respectively, and RCLs were associated with a significant increase in cannabis poisoning by 0.34 (95% CI, 0.19-0.48; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) per 100\u202f000 enrollees per quarter in states with RCLs compared to states without these laws. No significant associations were observed for MCDs or HC-MC. Relative increases in CUD associated with MCLs were higher among female enrollees and among enrollees aged 35 to 44 years compared with male enrollees and other age groups, respectively. Sensitivity analysis results of 2011 to 2019 data were consistent with the 2011 to 2021 results.<\/jats:p><\/jats:sec><jats:sec id=\"ab-yoi240082-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this longitudinal cohort study, MCLs were associated with increased CUD and cannabis poisoning diagnoses, and RCLs were associated with increased cannabis poisoning in adults aged 18 to 64 years with employer-sponsored health insurance. Communities with increased access to cannabis may experience increased health care use and costs due to increases in cannabis poisoning and CUD, and new clinical and policy interventions are needed to curb these rising diagnoses.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2024.4145","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T16:03:35Z","timestamp":1734969815000},"page":"228","source":"Crossref","is-referenced-by-count":20,"title":["Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning"],"prefix":"10.1001","volume":"82","author":[{"given":"Jayani","family":"Jayawardhana","sequence":"first","affiliation":[{"name":"Department of Health Management and Policy, College of Public Health, University of Kentucky, Lexington"},{"name":"Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Health Management and Policy, College of Public Health, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Freeman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery C.","family":"Talbert","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Informatics, College of Medicine, University of Kentucky, Lexington"},{"name":"Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"yoi240082r1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/jamainternmed.2018.0266","article-title":"Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population.","volume":"178","author":"Bradford","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"2","key":"yoi240082r2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11121-018-0903-8","article-title":"The effect of medical marijuana laws on marijuana-related attitude and perception among US adolescents and young adults.","volume":"20","author":"Wen","year":"2019","journal-title":"Prev Sci"},{"issue":"2","key":"yoi240082r6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamapsychiatry.2019.3254","article-title":"Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016.","volume":"77","author":"Cerd\u00e1","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"yoi240082r7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.copsyc.2021.03.005","article-title":"Trends over time in adult cannabis use: a review of recent findings.","volume":"38","author":"Hasin","year":"2021","journal-title":"Curr Opinion Psychol"},{"issue":"4","key":"yoi240082r8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jamainternmed.2019.7517","article-title":"Trends in cannabis use among older adults in the United States, 2015-2018.","volume":"180","author":"Han","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"3","key":"yoi240082r9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/00952990.2021.2007257","article-title":"Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic.","volume":"48","author":"Assaf","year":"2022","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"yoi240082r10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1176\/appi.ajp.2017.17040413","article-title":"Cannabis use and risk of prescription opioid use disorder in the United States.","volume":"175","author":"Olfson","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"6","key":"yoi240082r11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/00952990.2019.1669626","article-title":"Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: findings from state policy evaluations.","volume":"45","author":"Smart","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"12","key":"yoi240082r12","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1111\/add.16280","article-title":"The impact of cannabis legalization and decriminalization on acute poisoning: a systematic review.","volume":"118","author":"Allaf","year":"2023","journal-title":"Addiction"},{"key":"yoi240082r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.05.008","article-title":"Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.","volume":"204","author":"Compton","year":"2019","journal-title":"Drug Alcohol Dependence"},{"issue":"10","key":"yoi240082r14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.22010034","article-title":"Trends in cannabis use disorder diagnoses in the U.S. Veterans Health Administration, 2005-2019.","volume":"179","author":"Hasin","year":"2022","journal-title":"Am J Psychiatry"},{"key":"yoi240082r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106479","article-title":"What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis.","volume":"109","author":"Leung","year":"2020","journal-title":"Addict Behav"},{"issue":"4","key":"yoi240082r18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jamapsychiatry.2023.0019","article-title":"State cannabis legalization and cannabis use disorder in the US Veterans Health Administration, 2005 to 2019.","volume":"80","author":"Hasin","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi240082r21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jdpa-2014-0001","article-title":"Words can be deceiving: a review of variation among legally effective medical marijuana laws in the United States.","volume":"7","author":"Pacula","year":"2014","journal-title":"J Drug Policy Analysis"},{"issue":"1","key":"yoi240082r22","first-page":"39","article-title":"State medical marijuana implementation and federal policy.","volume":"16","author":"O\u2019Keefe","year":"2013","journal-title":"J Health Care Law Policy"},{"issue":"6","key":"yoi240082r23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jamapsychiatry.2017.0724","article-title":"US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013.","volume":"74","author":"Hasin","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"yoi240082r24","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1111\/add.15019","article-title":"The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.","volume":"115","author":"Shi","year":"2020","journal-title":"Addiction"},{"issue":"12","key":"yoi240082r25","doi-asserted-by":"publisher","first-page":"e969","DOI":"10.1097\/PEC.0000000000001841","article-title":"Prevalence and clinical characteristics of unintentional ingestion of marijuana in children younger than 6 years in states with and without legalized marijuana laws.","volume":"37","author":"Leubitz","year":"2021","journal-title":"Pediatr Emerg Care"},{"issue":"8","key":"yoi240082r26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.9456","article-title":"Incidence of pediatric cannabis exposure among children and teenagers aged 0 to 19 years before and after medical marijuana legalization in Massachusetts.","volume":"2","author":"Whitehill","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"yoi240082r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.36571","article-title":"Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US.","volume":"4","author":"Jeffers","year":"2021","journal-title":"JAMA Netw Open"},{"key":"yoi240082r29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jhealeco.2017.12.007","article-title":"Do medical marijuana laws reduce addictions and deaths related to pain killers?","volume":"58","author":"Powell","year":"2018","journal-title":"J Health Econ"},{"issue":"2","key":"yoi240082r30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/1475-6773.13632","article-title":"The associations of medical marijuana policies with opioid-related health care utilization.","volume":"56","author":"Jayawardhana","year":"2021","journal-title":"Health Serv Res"},{"issue":"2","key":"yoi240082r37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jama.2016.18900","article-title":"Use of marijuana for medical purposes among adults in the United States.","volume":"317","author":"Compton","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"yoi240082r38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamainternmed.2018.1007","article-title":"Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees.","volume":"178","author":"Wen","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"5","key":"yoi240082r39","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/hec.4237","article-title":"The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insurance.","volume":"30","author":"Wen","year":"2021","journal-title":"Health Econ"},{"key":"yoi240082r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104140","article-title":"The impact of Medicaid expansion on mental health and substance use related inpatient visits.","volume":"119","author":"Jayawardhana","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"1","key":"yoi240082r41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/08897077.2021.1941521","article-title":"Impact of Medicaid expansion on mental health and substance use related emergency department visits.","volume":"43","author":"Jayawardhana","year":"2022","journal-title":"Subst Abus"},{"issue":"2","key":"yoi240082r43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jeconom.2020.12.001","article-title":"Difference-in-differences with multiple time periods.","volume":"225","author":"Callaway","year":"2021","journal-title":"J Econometrics"},{"issue":"4","key":"yoi240082r45","first-page":"1313","article-title":"Cannabis legalization in state legislatures: public health opportunity and risk.","volume":"103","author":"Orenstein","year":"2020","journal-title":"Marquette Law Rev"},{"issue":"11","key":"yoi240082r46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.40526","article-title":"Evaluation of cannabis use among US adults during the COVID-19 pandemic within different legal frameworks.","volume":"5","author":"Black","year":"2022","journal-title":"JAMA Netw Open"},{"key":"yoi240082r16","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013","edition":"5th ed"},{"key":"yoi240082r42","volume-title":"Two-stage differences in differences","author":"Gardner","year":"2021"},{"key":"yoi240082r3","unstructured":"Justice Department submits proposed regulation to reschedule marijuana. US Department of Justice. Accessed May 19, 2024. https:\/\/www.justice.gov\/opa\/pr\/justice-department-submits-proposed-regulation-reschedule-marijuana"},{"key":"yoi240082r4","unstructured":"State-by-state recreational marijuana laws. Britannica ProCon.org. Accessed May 14, 2024. https:\/\/marijuana.procon.org\/legal-recreational-marijuana-states-and-dc\/"},{"key":"yoi240082r5","unstructured":"Marijuana legality by state. DISA Global Solutions. Accessed May 14, 2024. https:\/\/disa.com\/marijuana-legality-by-state"},{"key":"yoi240082r15","unstructured":"Understanding your risk for cannabis use disorder. US Centers for Disease Control and Prevention. Accessed May 7, 2024. https:\/\/www.cdc.gov\/cannabis\/health-effects\/cannabis-use-disorder.html"},{"key":"yoi240082r19","unstructured":"Cannabis and poisoning. US Centers for Disease Control and Prevention. Accessed May 7, 2024. https:\/\/www.cdc.gov\/cannabis\/health-effects\/poisoning.html"},{"key":"yoi240082r20","unstructured":"Cannabis poisoning. California Department of Public Health. Accessed May 7, 2024. https:\/\/www.cdph.ca.gov\/Programs\/CCDPHP\/sapb\/cannabis\/Pages\/Cannabis-Poisoning.aspx"},{"key":"yoi240082r28","unstructured":"OPTIC-vetted policy data sets. RAND Corporation. Accessed May 16, 2023. https:\/\/www.rand.org\/health-care\/centers\/optic\/resources\/datasets.html"},{"key":"yoi240082r31","unstructured":"Davis? C, Lieberman? A, Larkin? K. Naloxone prescription mandates. The Network for Public Health Law\u2019s Harm Reduction Legal Project. https:\/\/www.networkforphl.org\/wp-content\/uploads\/2023\/09\/Fact-Sheet-Naloxone-Prescription-Mandates.pdf"},{"key":"yoi240082r32","unstructured":"Status of state action on the Medicaid expansion decision. Kaiser Family Foundation. Accessed October 11, 2023. https:\/\/www.kff.org\/health-reform\/state-indicator\/state-activity-around-expanding-medicaid-under-the-affordable-care-act\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D"},{"key":"yoi240082r33","unstructured":"US census data for social, economic, and health research. IPUMS Center for Data Integration. Accessed May 23, 2024. https:\/\/usa.ipums.org\/usa\/"},{"key":"yoi240082r34","unstructured":"US Census Bureau. Median Household Income by State. Accessed November 3, 2018. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/income-poverty\/historical-income-households.html"},{"key":"yoi240082r35","unstructured":"Average annual unemployment rates by state. US Bureau of Labor Statistics. Accessed November 3, 2018. https:\/\/www.bls.gov\/lau\/lastrk17.htm"},{"key":"yoi240082r36","unstructured":"Tax Policy Center. State alcohol excise tax rates. Urban Institute & Brookings Institute. Accessed March 10, 2018. https:\/\/taxpolicycenter.org\/statistics\/state-alcohol-excise-tax-rates"},{"key":"yoi240082r44","unstructured":"Gardner? J. Two-stage differences in differences.? arXiv. Preprint posted online July 13, 2022. doi:10.48550\/arXiv.2207.05943"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2828352\/jamapsychiatry_jayawardhana_2024_oi_240082_1740504098.38619.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:03:59Z","timestamp":1741190639000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2828352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.4145","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}